PSY Stock Overview
Through its subsidiary, Blossom Analysis, provides a data and insights platform for the psychedelic healthcare industry. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Shortwave Life Sciences Plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.003 |
| 52 Week High | UK£0 |
| 52 Week Low | UK£0 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | -33.33% |
| 1 Year Change | -90.16% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -92.50% |
Recent News & Updates
Recent updates
Shareholder Returns
| PSY | GB Healthcare Services | GB Market | |
|---|---|---|---|
| 7D | 0% | -4.2% | -2.6% |
| 1Y | -90.2% | 16.8% | 2.7% |
Return vs Industry: PSY underperformed the UK Healthcare Services industry which returned 13.3% over the past year.
Return vs Market: PSY underperformed the UK Market which returned 3.5% over the past year.
Price Volatility
| PSY volatility | |
|---|---|
| PSY Average Weekly Movement | 9.2% |
| Healthcare Services Industry Average Movement | 6.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 10.5% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: PSY's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: PSY's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2021 | n/a | Rivki Stern-Youdkevich | shortwavelifesciences.com |
Shortwave Life Sciences Plc, through its subsidiary, Blossom Analysis, provides a data and insights platform for the psychedelic healthcare industry. It offers a Software as a Service platform for scientific and regulatory data. The company was formerly known as Psych Capital Plc and changed its name to Shortwave Life Sciences Plc in June 2024.
Shortwave Life Sciences Plc Fundamentals Summary
| PSY fundamental statistics | |
|---|---|
| Market cap | UK£871.82k |
| Earnings (TTM) | UK£0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs PSY overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PSY income statement (TTM) | |
|---|---|
| Revenue | UK£0 |
| Cost of Revenue | UK£0 |
| Gross Profit | UK£0 |
| Other Expenses | UK£0 |
| Earnings | UK£0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did PSY perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 12:10 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | N/A |
| Annual Earnings | N/A |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Shortwave Life Sciences Plc is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|